Ocean Biomedical, Inc. (OCEA) Debt-to-equity % [USD] 2022 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ocean Biomedical, Inc. quarterly Debt-to-equity history and growth rate from 2022 to 2023.
  • Ocean Biomedical, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -103 %, a 121% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -103 -56.3 -121% Sep 30, 2023
Q2 2023 -99.8 -46 -85.4% Jun 30, 2023
Q1 2023 -90.2 Mar 31, 2023
Q4 2022 -65.8 Dec 31, 2022
Q3 2022 -46.4 Sep 30, 2022
Q2 2022 -53.8 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.